by McKesson Ventures | Dec 14, 2021 | Portfolio News
A two-part interview with AllStripes co-founder Nancy Yu on PatientWorthy went in depth about Yu’s background, why she started the company, and plans for the future. It begins by highlighting her interest in how science and technology interact with one another. Yu...
by McKesson Ventures | Oct 1, 2021 | Portfolio News
AllStripes, formerly known as RDMD, recently completed a $50 million venture round, which it will use to launch 100 new rare disease research programs. Global Genes recently interviewed AllStripes Co-founder and CEO Nancy Yu about the growing efforts around patient...
by McKesson Ventures | Sep 28, 2021 | Press Releases
AllStripes, a healthcare technology company dedicated to unlocking new treatments for people affected by rare diseases, has hired Sherwin Chen as chief legal officer and Joe Walsh as vice president and head of commercial. Chen is an experienced counsel specializing in...
by McKesson Ventures | Aug 24, 2021 | Portfolio News
AllStripes recently closed a $50 million Series B funding round led by Lux Capital, with participation from McKesson Ventures, JAZZ Venture Partners, Spark Capital, Medidata Solutions (a Dassault Systèmes company), and Maveron, along with angel investors including...
